North America Ophthalmic Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

North America Ophthalmology Drugs and Devices Market is segmented by product (devices (surgical devices and diagnostic devices) and drugs (glaucoma drugs, retinal disorder drugs, dry eye drugs, allergic conjunctivitis and inflammation drugs, and other drugs)), disease (glaucoma, cataract, age-related macular degeneration, inflammatory diseases, refractive disorders, other diseases), and geography (United States, Canada, and Mexico). The report offers value (in USD million) for the above segments.

North America Ophthalmic Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

North America Ophthalmic Drugs and Devices Industry Overview

The North America ophthalmic devices & drugs market is fragmented in nature. In terms of market share, a few of the major players are currently dominating the market. Some of the key operating players in the market are Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Essilor International SA, Haag-Streit Group, Johnson & Johnson, Nidek Co. Ltd, Topcon Corporation, and Ziemer Group AG.

North America Ophthalmic Drugs and Devices Market Leaders

  1. Alcon Inc.

  2. Carl Zeiss Meditec AG

  3. Haag-Streit Group

  4. Johnson & Johnson

  5. Bausch Health Companies Inc. (Bausch + Lomb)

  6. *Disclaimer: Major Players sorted in no particular order
North America Ophthalmic Devices & Drugs Market Concentration.png